CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 144 Insider Sale of Securities
- 4 Gift Director gave 2,600 shares (gift)
- 4 Option exercise Director acquired 403 shares (option exercise)
- 4 Open-market sale Director sold 3,673 shares at $81.43 ($299,092)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Conversion CHAIRMAN & CEO acquired 900,000 shares (conversion)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Grant or award Director acquired 12,156 shares (grant or award)
- 8-K Event Shareholder vote results
Page 2 of 39 · 777 filings